Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.11B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$317M |
| 3 |
Linde
LIN
|
+$290M |
| 4 |
Danaher
DHR
|
+$275M |
| 5 |
Home Depot
HD
|
+$246M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$732M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$731M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$574M |
| 4 |
Meta Platforms (Facebook)
META
|
+$573M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$484M |
Sector Composition
| 1 | Financials | 16.4% |
| 2 | Technology | 14.23% |
| 3 | Healthcare | 12.49% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3726
GameSquare
GAME
$72.3M
| $36K | ﹤0.01% |
+60,444
| New | +$36K |
|
3727
Stereotaxis
STXS
$262M
| $35.2K | ﹤0.01% |
+19,975
| New | +$35.2K |
|
3728
Immuneering
IMRX
$341M
| $35.1K | ﹤0.01% |
23,065
-79,871
| -78% | -$121K |
|
3729
Alto Neuroscience
ANRO
$106M
| $34.9K | ﹤0.01% |
+16,179
| New | +$34.9K |
|
3730
Zynex
ZYXI
$46.7M
| $34.8K | ﹤0.01% |
15,817
-12,909
| -45% | -$28.4K |
|
3731
WM Technology
MAPS
$135M
| $34.7K | ﹤0.01% |
+30,699
| New | +$34.7K |
|
3732
LivePerson
LPSN
$91.8M
| $33.8K | ﹤0.01% |
42,279
-768,929
| -95% | -$614K |
|
|
GCL
3733
GCL Global Holdings Ltd Ordinary Shares
GCL
$375M
| $31.3K | ﹤0.01% |
+16,045
| New | +$31.3K |
|
3734
Tilray
TLRY
$1.16B
| $30.8K | ﹤0.01% |
46,824
-614,010
| -93% | -$404K |
|
|
VIOT
3735
Viomi Technology
VIOT
$243M
| $30K | ﹤0.01% |
+19,247
| New | +$30K |
|
3736
Context Therapeutics
CNTX
$75M
| $29.8K | ﹤0.01% |
48,671
-130,047
| -73% | -$79.6K |
|
3737
Solitario Resources
XPL
$70.5M
| $28.8K | ﹤0.01% |
48,042
-25,473
| -35% | -$15.3K |
|
3738
Altisource Portfolio Solutions
ASPS
$124M
| $28.7K | ﹤0.01% |
5,267
+259
| +5% | +$1.41K |
|
|
AHG
3739
Akso Health Group
AHG
$1.01B
| $27.9K | ﹤0.01% |
22,833
+4,829
| +27% | +$5.89K |
|
|
IPHA
3740
Innate Pharma
IPHA
$188M
| $27.3K | ﹤0.01% |
+15,326
| New | +$27.3K |
|
3741
United Homes Group
UHG
$259M
| $27.3K | ﹤0.01% |
28,536
-9,458
| -25% | -$9.04K |
|
|
IMMP
3742
Immutep
IMMP
$244M
| $27.1K | ﹤0.01% |
15,405
-962
| -6% | -$1.69K |
|
|
STRK
3743
Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock
STRK
$690M
| $26.8K | ﹤0.01% |
+32,600
| New | +$26.8K |
|
|
VRPX
3744
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $26.5K | ﹤0.01% |
+22,075
| New | +$26.5K |
|
|
GAU
3745
Galiano Gold
GAU
$644M
| $26.4K | ﹤0.01% |
21,479
-5,442
| -20% | -$6.7K |
|
|
BTOC
3746
Armlogi Holding Corp
BTOC
$53.1M
| $26.3K | ﹤0.01% |
26,260
+4,935
| +23% | +$4.94K |
|
3747
Diana Shipping
DSX
$217M
| $25.6K | ﹤0.01% |
16,414
-122,133
| -88% | -$191K |
|
3748
Alto Ingredients
ALTO
$89.8M
| $24.5K | ﹤0.01% |
21,507
-10,188
| -32% | -$11.6K |
|
|
VIGL
3749
DELISTED
Vigil Neuroscience
VIGL
| $24.2K | ﹤0.01% |
13,575
-330,239
| -96% | -$588K |
|
3750
Tenaya Therapeutics
TNYA
$209M
| $24K | ﹤0.01% |
42,050
-112,178
| -73% | -$64K |
|